Jason McCarthy Reiterates Buy on INmune Bio, Keeps $8 Price Target Amid Advancing Clinical and Regulatory Milestones
at www.tipranks.com (Thu, 13-Aug 10:05 AM)
INmune Bio Secures Rapid UK Regulatory Progress for Ebstrocel, Paving Way for First Systemic RDEB Therapy
Market Chameleon (Thu, 25-Jun 11:16 AM)
